Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial

Published on May 1, 2020in Pediatrics5.359
· DOI :10.1542/PEDS.2019-3182
Cynthia Sharpe9
Estimated H-index: 9
(UCSD: University of California, San Diego),
Gail E. Reiner7
Estimated H-index: 7
(UCSD: University of California, San Diego)
+ 22 AuthorsRichard H. Haas44
Estimated H-index: 44
(UCSD: University of California, San Diego)
Sources
Abstract
BACKGROUND AND OBJECTIVES: There are no US Food and Drug Administration–approved therapies for neonatal seizures. Phenobarbital and phenytoin frequently fail to control seizures. There are concerns about the safety of seizure medications in the developing brain. Levetiracetam has proven efficacy and an excellent safety profile in older patients; therefore, there is great interest in its use in neonates. However, randomized studies have not been performed. Our objectives were to study the efficacy and safety of levetiracetam compared with phenobarbital as a first-line treatment of neonatal seizures. METHODS: The study was a multicenter, randomized, blinded, controlled, phase IIb trial investigating the efficacy and safety of levetiracetam compared with phenobarbital as a first-line treatment for neonatal seizures of any cause. The primary outcome measure was complete seizure freedom for 24 hours, assessed by independent review of the EEGs by 2 neurophysiologists. RESULTS: Eighty percent of patients (24 of 30) randomly assigned to phenobarbital remained seizure free for 24 hours, compared with 28% of patients (15 of 53) randomly assigned to levetiracetam (P CONCLUSIONS: In this phase IIb study, phenobarbital was more effective than levetiracetam for the treatment of neonatal seizures. Higher rates of adverse effects were seen with phenobarbital treatment. Higher-dose studies of levetiracetam are warranted, and definitive studies with long-term outcome measures are needed.
📖 Papers frequently viewed together
252 Citations
420 Citations
10 Citations
References50
Newest
#2Ayesha RomanaH-Index: 1
Last. Asha BenakappaH-Index: 6
view all 5 authors...
Objective To compare the efficacy and safety of intravenous Levetiracetam and Phenobarbitone in the treatment of neonatal seizures.
13 CitationsSource
#1Janet S. Soul (Boston Children's Hospital)H-Index: 37
#2Ronit M. PresslerH-Index: 26
Last. Jonathan M. Davis (Floating Hospital for Children)H-Index: 55
view all 18 authors...
Although seizures have a higher incidence in neonates than any other age group and are associated with significant mortality and neurodevelopmental disability, treatment is largely guided by physician preference and tradition, due to a lack of data from welldesigned clinical trials. There is increasing interest in conducting trials of novel drugs to treat neonatal seizures, but the unique characteristics of this disorder and patient population require special consideration with regard to trial d...
23 CitationsSource
#1Cynthia SharpeH-Index: 9
#2Suzanne L DavisH-Index: 2
Last. Richard H. Haas (UCSD: University of California, San Diego)H-Index: 44
view all 22 authors...
Purpose: Continuous video electroencephalography (cEEG) monitoring is the recommended gold standard of care for at-risk neonates but is not available in many Neonatal Intensive Care Units (NICUs). To conduct a randomized treatment trial of levetiracetam for the first-line treatment of neonatal seizures (the NEOLEV2 trial), we developed a monitoring infrastructure at five NICUs, implementing recent technological advancements to provide continuous video EEG monitoring and real-time response to sei...
11 CitationsSource
#1Lekha M. Rao (Boston Children's Hospital)H-Index: 3
#2Shaun A. Hussain (Boston Children's Hospital)H-Index: 18
Last. Raman Sankar (UCLA: University of California, Los Angeles)H-Index: 66
view all 7 authors...
Abstract Purpose Seizures are common in term infants with hypoxic–ischemic encephalopathy (HIE) undergoing therapeutic hypothermia. Although phenobarbital (PHB) is generally considered first-line therapy, some centers have embraced third-generation antiepileptic drugs (AEDs) such as levetiracetam (LEV) given the impression of comparable efficacy and superior tolerability. We set out to compare the efficacy of PHB and LEV in a large single-center cohort. Methods We retrospectively identified cons...
20 CitationsSource
#1Daryl C. McHugh (The Neurosciences Institute)H-Index: 1
#2Shannon Lancaster (The Neurosciences Institute)H-Index: 1
Last. Louis N. Manganas (The Neurosciences Institute)H-Index: 1
view all 3 authors...
Objective Seizures are the most common neurological complication in neonatal intensive care units. Phenobarbital (PB) remains the first-line antiepileptic drug (AED) for neonatal seizures despite known neurotoxicity. Levetiracetam (LEV) is a newer AED not approved for neonates. Retrospective and pilot studies have investigated the use of LEV in neonatal seizures. Our objective was to compare the efficacy of LEV to PB in neonatal seizures based upon published data. Methods We searched PubMed to p...
30 CitationsSource
BACKGROUND: Neonatal seizures are the most common clinical manifestation of Central Nervous System (CNS) dysfunction and are associated with various neurological sequelae. There are currently no evidence-based guidelines for the management of neonatal seizures and currently used drugs such as phenobarbital, and phenytoin have limited efficacy and potential toxicities. Newer second line anticonvulsant, levetiracetam, has been used in refractory neonatal seizures despite limited data and off-label...
11 CitationsSource
#1Anneleen Dereymaeker (Katholieke Universiteit Leuven)H-Index: 11
#2Amir Hossein Ansari (Katholieke Universiteit Leuven)H-Index: 9
Last. Gunnar Naulaers (Katholieke Universiteit Leuven)H-Index: 39
view all 13 authors...
Abstract Objective To assess interrater agreement based on majority voting in visual scoring of neonatal seizures. Methods An online platform was designed based on a multicentre seizure EEG-database. Consensus decision based on ‘majority voting’ and interrater agreement was estimated using Fleiss’ Kappa. The influences of different factors on agreement were determined. Results 1919 Events extracted from 280 h EEG of 71 neonates were reviewed by 4 raters. Majority voting was applied to assign a s...
8 CitationsSource
#1Courtney J. Wusthoff (Stanford University)H-Index: 28
#2Joseph Sullivan (UCSF: University of California, San Francisco)H-Index: 28
Last. Tammy Tsuchida (Columbia University)H-Index: 13
view all 7 authors...
SummaryObjective Research using neonatal electroencephalography (EEG) has been limited by a lack of a standardized classification system and interpretation terminology. In 2013, the American Clinical Neurophysiology Society (ACNS) published a guideline for standardized terminology and categorization in the description of continuous EEG in neonates. We sought to assess interrater agreement for this neonatal EEG categorization system as applied by a group of pediatric neurophysiologists. Methods A...
31 CitationsSource
#1Katja StrasserH-Index: 6
#2L. Lueckemann (University of Duisburg-Essen)H-Index: 2
Last. Ursula Felderhoff-MueserH-Index: 31
view all 9 authors...
Abstract Perinatal asphyxia to the developing brain remains a major cause of morbidity. Hypothermia is currently the only established neuroprotective treatment available for term born infants with hypoxic-ischemic encephalopathy, saving one in seven to eight infants from developing severe neurological deficits. Therefore, additional treatments with clinically applicable drugs are indispensable. This study investigates a potential additive neuroprotective effect of levetiracetam combined with hyp...
15 CitationsSource
#1Hannah C. Glass (UCSF: University of California, San Francisco)H-Index: 37
#2Renée A. Shellhaas (UM: University of Michigan)H-Index: 32
Last. Janet S. Soul (Boston Children's Hospital)H-Index: 37
view all 13 authors...
Objective To determine the contemporary etiology, burden, and short-term outcomes of seizures in neonates monitored with continuous video-electroencephalogram (cEEG). Study design We prospectively collected data from 426 consecutive neonates (56% male, 88% term) ≤44 weeks' postmenstrual age with clinically suspected seizures and/or electrographic seizures. Subjects were assessed between January 2013 and April 2015 at 7 US tertiary care pediatric centers following the guidelines of the American C...
104 CitationsSource
Cited By31
Newest
#1Andreea M Pavel (UCC: University College Cork)H-Index: 2
#2Janet M. Rennie (UCL: University College London)H-Index: 38
Last. Sean Mathieson (UCC: University College Cork)H-Index: 12
view all 16 authors...
Objective null To assess the impact of the time to treatment of the first electrographic seizure on subsequent seizure burden; secondary aim was to describe overall seizure management in a large neonatal cohort. null Study design null Newborns (36-44 weeks' gestation) requiring electroencephalographic (EEG) monitoring recruited to two multicentre European studies were included. Infants who received anti-seizure medication exclusively after electrographic seizure onset, were grouped based on time...
Source
#2Janette Mailo (Glenrose Rehabilitation Hospital)
Last. Taeun Chang (GW: George Washington University)H-Index: 30
view all 10 authors...
Neonatal encephalopathy (NE) is the most common etiology of acute neonatal seizures - about half of neonates treated with therapeutic hypothermia for NE have EEG-confirmed seizures. These seizures are best identified with continuous EEG monitoring, as clinical diagnosis leads to under-diagnosis of subclinical seizures and over-treatment of events that are not seizures. High seizure burden, especially status epilepticus, is thought to augment brain injury. Treatment, therefore, is aimed at minimi...
1 CitationsSource
#1Julie Ziobro (UM: University of Michigan)H-Index: 8
#2Krista Eschbach (CU: University of Colorado Boulder)H-Index: 6
Last. Renée A. Shellhaas (UM: University of Michigan)H-Index: 32
view all 3 authors...
Neonatal seizures are a common neurologic emergency for which therapies have not significantly changed in decades. Improvements in diagnosis and pathophysiologic understanding of the distinct features of acute symptomatic seizures and neonatal-onset epilepsies present exceptional opportunities for development of precision therapies with potential to improve outcomes. Herein, we discuss the pathophysiology of neonatal seizures and review the evidence for currently available treatment. We present ...
Source
Source
#1Tuomas Koskela (UCL: University College London)
#2Giles S Kendall (UCL: University College London)H-Index: 10
Last. Kimberley Whitehead (UCL: University College London)H-Index: 12
view all 10 authors...
Abstract null null Objective null Early prediction of neurological deficits following neonatal hypoxic-ischemic encephalopathy (HIE) may help to target support. Neonatal animal models suggest that recovery following hypoxia-ischemia depends upon cortical bursting. To test whether this holds in human neonates, we correlated the magnitude of cortical bursting during recovery (≥postnatal day 3) with neurodevelopmental outcomes. null null null Methods null We identified 41 surviving infants who rece...
Source
#6Qi-Xiong Chen (CQMU: Chongqing Medical University)H-Index: 4
#7Jing-Kun MiaoH-Index: 2
Background null Anti-epileptic drugs have different effects on neonatal seizures, and new agents have been widely used in recent years. Meanwhile, significant differences still exist in the treatment for neonatal seizures, whether in choice of drug or in duration of treatment. And with the increase in options for treatment, the best choice of second-line treatment has not been recommended. null null null Methods null The MEDLINE, the Cochrane Library, Web of Science, Embase and null clinicaltria...
Source
#1Hannah C. Glass (UCSF: University of California, San Francisco)H-Index: 37
#2Janet S. Soul (Boston Children's Hospital)H-Index: 37
Last. Renée A. Shellhaas (UM: University of Michigan)H-Index: 32
view all 17 authors...
Importance Antiseizure medication (ASM) treatment duration for acute symptomatic neonatal seizures is variable. A randomized clinical trial of phenobarbital compared with placebo after resolution of acute symptomatic seizures closed early owing to low enrollment. Objective To assess whether ASM discontinuation after resolution of acute symptomatic neonatal seizures and before hospital discharge is associated with functional neurodevelopment or risk of epilepsy at age 24 months. Design, Setting, ...
4 CitationsSource
#1Eric T. Payne (Alberta Children's Hospital)H-Index: 16
#2Elaine C. Wirrell (Mayo Clinic)H-Index: 63
Source
#1Alexey Pospelov (UH: University of Helsinki)H-Index: 4
#2Tommi Ala-Kurikka (UH: University of Helsinki)H-Index: 2
Last. Kai Kaila (UH: University of Helsinki)H-Index: 84
view all 5 authors...
Objective null Seizures are common in neonates recovering from birth asphyxia but there is general consensus that current pharmacotherapy is suboptimal and that novel antiseizure drugs are needed. We recently showed in a rat model of birth asphyxia that seizures are triggered by the post-asphyxia recovery of brain pH. Here our aim was to investigate whether carbonic anhydrase inhibitors (CAIs), which induce systemic acidosis, block the post-asphyxia seizures. null Methods null The CAIs acetazola...
1 CitationsSource
#1Wolfgang Löscher (University of Veterinary Medicine Vienna)H-Index: 95
#2Pavel KleinH-Index: 19
Epilepsy is one of the most common and disabling chronic neurological disorders. Antiseizure medications (ASMs), previously referred to as anticonvulsant or antiepileptic drugs, are the mainstay of symptomatic epilepsy treatment. Epilepsy is a multifaceted complex disease and so is its treatment. Currently, about 30 ASMs are available for epilepsy therapy. Furthermore, several ASMs are approved therapies in nonepileptic conditions, including neuropathic pain, migraine, bipolar disorder, and gene...
1 CitationsSource